The current view of adjuvant hormonal treatment of premenopausal patients with breast cancer

Abstract

Adjuvant hormonal therapy is a key component of treatment for young patients with estrogen receptor positive breast cancer, ensuring patients a significant improvement in the chances of full health. Its right composition and sequence to other therapeutic modalities (chemotherapy, radiotherapy, biological therapy) ensure maximum efficiency.

Keywords

• Breast cancer
• premenopausal status
• hormonal therapy
• tamoxifen
• goserelin